# Polidocanol Sclerotherapy in Hereditary Hemorrhagic Telangiectasia Patients Does Not Seem to Decrease Epistaxis‐Related Outpatient and Emergency Visits—A Retrospective View

**Authors:** Elsa‐Leea Kotola, Johanna Wikstén, Eeva Castrén

PMC · DOI: 10.1111/coa.70059 · Clinical Otolaryngology · 2025-11-12

## Full-text entities

- **Diseases:** Hereditary Hemorrhagic Telangiectasia (MESH:D013683), Epistaxis (MESH:D004844)
- **Chemicals:** Polidocanol (MESH:D000077423)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868990/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12868990/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12868990/full.md

---
Source: https://tomesphere.com/paper/PMC12868990